Current members

• Isa Tas, PhD                                     (Assistant researcher, Dec 2025 - ) Project: Understanding the immune microenvironment of cancer and therapy resistance 

• Lei Zhang, MD                                (PhD student, June 2025 - ) Project:  Understanding the mechanisms of therapy resistance in ovarian cancer

• Maryam Sanjari Pour, PhD     (Postdoc, June 2025 - ) Project:  Targeted combination therapy in relapsed T-cell acute lymphoblastic leukemia

• Adam Kai Aragaki, PhD             (Postdoc, Mar 2025 - ) Project:  Optimizing Machine Learning Algorithms for Cancer Detection         

• Ahmad Nasimian, PhD               (Guest Researcher, Nov 2024 – At present)

• Julhash Uddin Kazi    (PI) @LU @RG @ORCID

Former members

Postdocs

• Ahmad Nasimian, PhD               (Postdoc, Nov 2021 – October 2024) Project: The mechanisms of drug resistance in cancer and the role of BCL2 family proteins.

• Mehreen Ahmed, PhD                (Postdoc, Aug 2020 – July 2022) Project: The transcriptional and post-translational regulation of AXL in drug-resistant epithelial ovarian cancer.

• Amal Maouia, PhD                        (July 2018 – Jun 2019) Project: Deregulation of the cell cycle in acute lymphoblastic leukemia.

• Mohiuddin Gazi, PhD                  (Sep 2015 – Aug 2017 ) Project: PI3K/mTOR pathway dependency in acute lymphoblastic leukemia

PhD students

• Kinjal Shah                                         (Nov 2017 – Oct 2021) Thesis: Mechanisms of therapy resistance in acute lymphoblastic leukemia.

• Alissa Marhäll                                  (Nov 2015 – Apr 2018) Thesis: Translational studies on acute myeloid leukemia focus on the receptor tyrosine kinase FLT3.

Research students

• Lina Al-Ashiri                                    (Jun 2019 – Jan 2020) Project: The transcriptional and post-translational regulation of AXL in drug-resistant epithelial ovarian cancer.

• Fatima Khanum                               (Feb 2016 – Jun 2016) Project: Development of targeted therapy against Acute Myeloid Leukemia.

Master’s students

• Beatriz Rubio Hombrados        (January 2024 – June 2024) Thesis: Targeting FUT8-Driven Core Fucosylation.

• Laila Mousafi Alasal                     (January 2024 – June 2024) Thesis: Estimating Cancer Drug Combination Scores with Minimal Drug Sensitivity Data.

• Elham Akbari Asl                           (March 2023 - October 2023) Thesis: Role of FUT8 in the regulation of cellular signaling in ovarian cancer.

• Linn Denison                                   (August 2022 - June 2023) Thesis: Role of PLK1 in the regulation of mitochondrial programmed cell death.

• Margaux Oberling                       (Jan 2021 – June 2021) Thesis: Temporal regulation of AXL expression in therapy-resistant leukemia.

• Hongzhi Duan                                (Nov2020 - Jun 2021) Thesis: Inhibition of Oncogenic FLT3 Prevents Ferroptosis in Leukemia Cell Models.

• Lina Al-Ashiri                                  (Jul 2018 – Jun 2019) Thesis: The Role of AXL in Acute Myeloid Leukemia.

• Sara Al-Safar                                  (Sep 2018 – Jun 2019) Thesis: Identification of Novel Signal Transduction Proteins of Importance for AXL Signaling.

• Felix Kronqvist                              (Jul 2018 – May 2019) Thesis: The role of bone marrow stromal cells in therapy resistance of FLT3-ITD positive acute myeloid leukemia cells.

• Kinjal Shah                                      (Jun 2016 – Jun 2017) Thesis: Role of the g-protein-coupled receptor p2ry14 in acute leukemia.

• Kaja Rupar                                      (Jun 2015 – Jun 2016) Thesis: The role of SRC-like adaptor protein 2 (SLAP2) in receptor tyrosine kinase KIT signaling.

• Sausan Moharram                     (Feb 2015 – Mar 2016) Thesis: Identification of novel signal transduction proteins of importance for FLT3 signaling in acute myeloid leukemia.

Bachelor students

• Hanna Barresjö                         (Jan 2018 – May 2018) Thesis: The mutational status of residue Y842 in FLT3 predicts the drug response to acute myeloid leukemia.

• Lucy Macaulay                          (Feb 2014 – May 2014) Thesis: Understanding the Mechanisms and specificity of pathway-specific inhibitors in the treatment of acute myeloid leukemia.

Updated: 2025-11-30